hematological tumor - pipeline review, h1 2014

10
www.MarketResearchReports.com Hematologica l Tumor - Pipeline Review, H1 2014 Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners.

Upload: market-research-reports-inc

Post on 20-Aug-2015

85 views

Category:

Healthcare


0 download

TRANSCRIPT

Page 1: Hematological Tumor - Pipeline Review, H1 2014

www.MarketResearchReports.com

Hematological Tumor - Pipeline

Review, H1 2014

Category : Pharma & Healthcare

All logos and Images mentioned on this slide belong to their respective owners.

Page 2: Hematological Tumor - Pipeline Review, H1 2014

www.MarketResearchReports.com

Introduction to Report

Launch Date: June 30, 2014

Number of Pages: 450

Geography Coverage: Global

Available Format: PDF

Price For Single User License: USD 2,000

Price For Site License: USD 4,000

Price For Global User License: USD 6,000

Delivery Time: Within 24 Hours (During Working Days)

Page 3: Hematological Tumor - Pipeline Review, H1 2014

www.MarketResearchReports.com

About the Report

This Report provides an overview of the Hematological Tumor’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hematological Tumor, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

It also reviews key players involved in the therapeutic development for Hematological Tumor and special features on late-stage and discontinued projects.

Page 4: Hematological Tumor - Pipeline Review, H1 2014

www.MarketResearchReports.com

Research Finding

Publisher’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.

Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Page 5: Hematological Tumor - Pipeline Review, H1 2014

www.MarketResearchReports.com

Scope

The report provides a snapshot of the global therapeutic landscape of Hematological Tumor

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in the therapeutics development for Hematological Tumor and enlists all their major and minor projects

The report summarizes all the dormant and discontinued pipeline projects

A review of the Hematological Tumor products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Page 6: Hematological Tumor - Pipeline Review, H1 2014

www.MarketResearchReports.com

Scope Continues…

Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Hematological Tumor pipeline on the basis of target, MoA, route of administration and molecule type

Latest news and deals relating related to pipeline products

Page 7: Hematological Tumor - Pipeline Review, H1 2014

www.MarketResearchReports.com

Report Coverage

1. Introduction

2. Hematological Tumor Overview

3. Therapeutics Development

4. Clinical Stage Products

5. Drug Profiles

6. Appendix

7. Methodology

For more details regarding Report coverage see the last slide

All logos and Images mentioned on this slide belong to their respective owners.

Page 8: Hematological Tumor - Pipeline Review, H1 2014

www.MarketResearchReports.com

Company Coverage (Partial List)

1. F. Hoffmann-La Roche Ltd.2. AstraZeneca PLC3. Eli Lilly and Company4. GlaxoSmithKline plc5. MedImmune, LLC6. Gilead Sciences, Inc.7. Merck & Co., Inc.8. AbGenomics International, Inc.9. Dainippon Sumitomo Pharma Co., Ltd.10.Gamida Cell Ltd.11.Infinity Pharmaceuticals, Inc.12.Symphogen A/S

For more details regarding Report coverage see the last slide

All logos and Images mentioned on this slide belong to their respective owners.

Page 9: Hematological Tumor - Pipeline Review, H1 2014

www.MarketResearchReports.com

Custom Research: Are you an industry professional, entrepreneur,

venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.

For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center

Page 10: Hematological Tumor - Pipeline Review, H1 2014

www.MarketResearchReports.com

How To Buy This Report?

Visit following URL to see Table of Content and purchase this publication:

http://mrr.cm/ZWx

About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.

Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)